KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Precigen (PGEN) Return on Sales (2016 - 2025)

Historic Return on Sales for Precigen (PGEN) over the last 14 years, with Q3 2025 value amounting to 50.08%.

  • Precigen's Return on Sales fell 249200.0% to 50.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 39.13%, marking a year-over-year decrease of 122500.0%. This contributed to the annual value of 4.02% for FY2022, which is 27100.0% up from last year.
  • Latest data reveals that Precigen reported Return on Sales of 50.08% as of Q3 2025, which was down 249200.0% from 31.12% recorded in Q2 2025.
  • Precigen's Return on Sales' 5-year high stood at 5.68% during Q3 2022, with a 5-year trough of 82.0% in Q2 2024.
  • Over the past 5 years, Precigen's median Return on Sales value was 0.18% (recorded in 2021), while the average stood at 14.29%.
  • As far as peak fluctuations go, Precigen's Return on Sales plummeted by -863000bps in 2024, and later surged by 508700bps in 2025.
  • Precigen's Return on Sales (Quarter) stood at 0.45% in 2021, then soared by 789bps to 4.02% in 2022, then grew by 7bps to 4.3% in 2023, then tumbled by -486bps to 16.58% in 2024, then crashed by -202bps to 50.08% in 2025.
  • Its Return on Sales stands at 50.08% for Q3 2025, versus 31.12% for Q2 2025 and 40.38% for Q1 2025.